A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients

V.B.C. Biemans, E. Savelkoul, R.Y. Gabriels, M. Simsek, G. Dijkstra, M.J. Pierik, R.L. West, N.K.H. de Boer, F. Hoentjen, Dutch Initiative on Crohn and Colitis (ICC)

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1076-1086
Number of pages11
JournalAlimentary Pharmacology & Therapeutics
Volume51
Issue number11
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • adverse events
  • azathioprine
  • combination therapy
  • crohns-disease
  • efficacy
  • infliximab
  • intensification
  • prevalence
  • safety
  • thioguanine
  • CROHNS-DISEASE
  • EFFICACY
  • SAFETY
  • COMBINATION THERAPY
  • AZATHIOPRINE
  • PREVALENCE
  • INTENSIFICATION
  • THIOGUANINE
  • INFLIXIMAB
  • ADVERSE EVENTS

Cite this